Phil Gotwals talks about his vision for the future of business development for research.
At Novartis, we celebrate life and recognize moments that matter. Michael Wieser shares his experience of parental leave and becoming a father of two.
Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
Caring for a baby with retinopathy of prematurity (ROP) has never been easy. But mother and social visionary Silke Mader has made it her life’s work to ensure that parents dealing with ROP and other complications today get more support than she did.
Advanced Accelerators Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.
For all too many people living with heart failure, hospitalizations are a recurring part of life, affecting the lives of both patients and their caregivers.
A collaboration in Ghana aims to expand early diagnosis and treatment of people with this inherited illness.
Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.
Christine Hà lost her vision at a young age – and went on to become an award-winning chef.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.